Competitor News, M&A

BC Platforms Acquires 4Pharma, a Leading International Provider of Medical Research Data and Analytics Services for Global Clinical Trials and Real World Data

ZURICH, Switzerland, June 01, 2023 (GLOBE NEWSWIRE) — BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the acquisition of 4Pharma Ltd, a well-established contract research organization providing medical research services to pharmaceutical, biotechnology, and medical device companies. Financial details are not disclosed. The acquisition…

Canada, Government/Regulatory, Industry News, International

Guidance for Reporting Real-World Evidence

CADTH has partnered with Health Canada, the Institut national d’excellence en santé et en services sociaux (INESSS), and other health system stakeholders to advance the integration of real-world evidence (RWE) into decision-making. Guidance for Reporting Real-World Evidence lays the foundation for the use of RWE in regulatory approval and Health Technology Assessment…

Collaborations, Partner and Collaborator News

Jacobs and Palantir Expand Partnership

Expansion focuses on commercializing new AI solutions across multiple sectors DALLAS and DENVER, May 31, 2023 /PRNewswire/ — Jacobs (NYSE: J) and Palantir Technologies Inc. (NYSE: PLTR) (“Palantir”) today announced an expansion of their partnership, focused on leveraging Palantir’s AI capabilities to commercialize new AI solutions spanning critical infrastructure, advanced facilities, supply chain management and more. “While…

Competitor News, Product Updates

DNAnexus Platform Streamlines Access and Analysis for Large-Scale Proteomics Data

May 31, 2023 08:03 AM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its core platform and Cohort Browser are now optimized for accessing and analyzing large-scale proteomics data. The optimizations were based on…

Collaborations, Competitor News, Oncology

Lifebit and Flatiron Health announce partnership to accelerate cancer data research

Today, 31 May 2023, Lifebit and Flatiron Health are announcing a multi-year strategic partnership to support vital research and enable scientific discoveries to improve and extend lives by learning from the experience of every person with cancer. Implementing Lifebit’s pioneering federated Trusted Research Environment technology will enable approved researchers to safely and…

Awards, Competitor News, Marketing

ConcertAI’s TeraRecon Receives ISO 27001 Certification

ConcertAI’s TeraRecon Inc. recognized as an ISO 27001:2022 certified company. CAMBRIDGE, Mass., May 30, 2023 /PRNewswire/ — TeraRecon, the advanced visualization and clinical AI SaaS category leader, today announced that it has been recognized as an International Organization for Standardization (ISO) 27001:2022 company, continuing its commitment to information security, cybersecurity, and privacy…

AI, Competitor News, Product Updates

ConcertAI’s TeraRecon adds Prostate Cancer Detection/Diagnosis into Eureka Clinical AI Platform with Bot Image, Inc. Partnership

CAMBRIDGE, Mass., May 26, 2023 /PRNewswire/ — The Eureka Clinical AI platform, from ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS category leader, now provides clinicians with the state-of-the-art clinical artificial intelligence and deep learning technology necessary to bring fast and accurate prostate cancer detection and diagnosis using bpMRI and AI in partnership with…

AI, Collaborations, Competitor News, Synthetic Data

Private AI and Replica Analytics announce partnership to tackle data privacy

TORONTO, May 25, 2023 /PRNewswire/ – Private AI, a leading provider of data privacy software solutions, and Replica Analytics Ltd., an Aetion® company, the leading Synthetic Data Generation technology provider for the healthcare industry, are pleased to announce a new partnership. The need for a privacy-preserving solution in healthcare is urgent and this strategic…